Long COVID in women and men are not the same disease. They share symptoms, but diverge in biology - immune, hormonal, and genetic.
After months since the preprint -
peer-reviewed study is now out in Cell Reports Medicine.🧵
This is the complete analysis immunity, hormones, and gene expression in 78 Long COVID with ME-CFS patients.
It confirms what patients have said for years -
this condition is biological, measurable, and deeply sex-specific.
In women, the immune system never stands down.
chronic inflammation, exhausted T cells, and loss of regulatory Tregs
leaky gut - constant immune activation
high IL-6, IL-1α, TNF-α, IFN-γ
low testosterone and cortisol - hormones that normally keep inflammation in check.
It’s not overreaction. It’s immune dysregulation.
Chronic inflammation meets hormonal collapse.
They also show an expansion of CD71+ erythroid cells - immature red cells released under stress.
These cells secrete ARTN, a neurotrophic factor linked to pain & cognitive fog.
It’s measurable biology.
In men, the story is different.
Less cytokine storm, more metabolic overload. Less inflammatory chaos, more mitochondrial stress.
Low estradiol, impaired mitochondrial function.
Signs of tissue repair rather than immune fire. The body tries to fix rather than fight.
They’re running a marathon on an empty battery.
The female form looks like autoimmune neuroinflammation.
Brain fog, pain, fatigue - but rooted in measurable biology.
The male form looks like chronic metabolic exhaustion.
Same symptoms. Different mechanisms.
Transcriptomic data reveal two distinct paths.
Women - neuroinflammation, oxidative stress, TGF-β activation
Men - mitochondrial metabolism, tissue repair.
Women burn. Men rebuild.
The authors propose Long COVID is a neuro-endocrine-immune disorder -
a breakdown of communication between the brain, hormones, and immune system.
And that treatment may need to be sex-specific.
testosterone support for women,
estradiol for men,
plus targeted anti-inflammatory and gut barrier therapies.
Both groups show signs of immune exhaustion.
T cells are stuck in a hyperactivated, terminal state -
unable to return to baseline.
It’s not weakness, it’s biology -
a system trapped between inflammation and burnout.
Loss of regulatory T cells (Tregs) may be the core driver.
Without these brakes, inflammation loops endlessly -
fueling pain, unrefreshing sleep, and cognitive dysfunction.
A body that can’t turn off its own alarm.
Low cortisol across both sexes points to HPA axis dysfunction -
the stress-response system that regulates immunity and energy.
That’s why many patients feel wired but tired.
Adrenal fatigue isn’t folklore - it’s measurable in plasma.
The upregulated genes in women - RELN, MEIS2, BRINP2, FEZF2 -
are all tied to neuronal plasticity and cognition.
This is the molecular fingerprint of brain fog.
Not psychosomatic. Transcriptional.
In men, it’s a different story.
Their gene profile shows a body locked in repair mode.
PALB2, BRCA2, PARP9 - DNA damage repair
CASP5, NLRP3, CLEC4D - low-grade inflammasome activity
HIF1A, SOD2, COX7A1 - mitochondrial stress response
Instead of runaway inflammation, there’s quiet exhaustion.
Macrophages cleaning debris
mitochondria running hot
cells constantly fixing damage instead of resting.
The message is clear:
Long COVID = systemic, measurable disorder
Hormones, immunity & neurons form one network
Personalized medicine starts here.
Treatment overview
The authors don’t propose one magic bullet -
but a map of disrupted systems that could guide therapy.
Hormonal balance, immune regulation, gut integrity, and metabolic recovery.
Each reflects a measurable fault line in Long COVID biology.
Hormonal modulation is key.
Low testosterone in women, low estradiol in men,
and low cortisol in both - all linked to immune imbalance.
Restoring this axis could help reset the system’s inflammatory threshold.
The study highlights loss of Treg cells (CD39) and gut barrier damage (I-FABP, LPS-BP, sCD14).
Therapies supporting immune regulation and gut repair are needed -
to stop the constant immune activation loop at its source.
While antivirals aren’t directly tested or proposed,
the team notes lingering interferon signatures (IFI27, IFI44L, OASL) -
a hint that residual viral antigens might sustain inflammation.
Future studies may need to explore this persistence.
Shahbaz at al. Cell Reports Medicine 2025. Integrated immune, hormonal, and transcriptomic profiling reveals sex-specific dysregulation in long COVID patients with ME/CFS. cell.com/cell-reports-m…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Getting the COVID and flu shot together?
A new Italian study in Cytokine found that the early inflammatory response after getting COVID-19 and flu vaccines at the same time may actually limit how long your antibody protection lasts🧵
29 healthcare workers received both
an mRNA COVID-19 (XBB.1.5) booster
a quadrivalent inactivated flu shot.
Blood was collected
before vaccination (T0)
5 days later (T1)
after 3 months (T2)
after 6 months (T3)
Within just 5 days, levels of inflammatory cytokines shot up -
especially IL-6, CXCL10, and TNF-α.
In some people, IL-8 also spiked and strongly correlated with IL-6.
That means their innate immune system went into high gear.
A new study from Hong Kong Baptist University examined how mRNA COVID-19 vaccines might influence insulin signaling.
The finding?
The spike protein can interfere with metabolic pathways - but mainly in people with type 2 diabetes (T2D)🧵
In mice given 4 doses of the mRNA vaccine, researchers observed impaired glucose tolerance, reduced insulin sensitivity, and higher triglycerides.
At the molecular level, phosphorylation of IRβ and Akt - key insulin signaling steps - was reduced.
Liver transcriptomics showed activation of NF-κB, MAPK, and AMPK-related pathways.
A new study in The Lancet Child & Adolescent Health followed nearly 14 million children in England.
It shows that SARS-CoV-2 infection leaves long-term marks on the vascular and immune system - even in kids.
Not just for weeks, but measurable up to a year later🧵
After COVID-19, children had a sharply increased risk of
systemic inflammatory syndromes (MIS-C, etc)
venous thrombosis
thrombocytopenia
myocarditis and pericarditis
And part of these risks remained elevated 12 months post-infection.
That means - even if a child feels fine after COVID, the body may stay in a dysregulated immune and vascular state - with lingering inflammation and endothelial stress.
In biological terms, COVID leaves a footprint
New study in BMC Immunology shows that COVID-19 leaves a lasting “aka Long Covid” imprint in the immune cells of older adults. What does that mean - and why does it matter?🧵
Months after recovery, immune cells in elderly people remain abnormally prone to die - through apoptosis.
Even when the virus is long gone, the immune system still shows signs of cellular damage and exhaustion.
Researchers analyzed peripheral blood mononuclear cells (PBMCs) - the core soldiers of the immune system, including T cells and monocytes.
In post-COVID seniors, twice as many cells were apoptotic compared to healthy controls.
A experimental study in Scientific Reports shows that the SARS-CoV-2 spike protein alone can trigger an autoimmune response against the ACE2 receptor - the very receptor the virus uses to enter cells.
The mechanism mirrors tissue damage seen in severe COVID-19🧵
This study is a proof-of-concept.
When the immune system reacts to the SARS-CoV-2 spike protein, part of that response can flip into autoimmunity against ACE2, the receptor the virus normally uses to enter cells.
In other words - the immune system doesn’t just make antibodies against the spike -
it can also generate anti-idiotype antibodies (and T-cell clones) that mistakenly recognize and attack ACE2, because ACE2 structurally mirrors the very site the spike protein binds to.
A massive Swedish study on Nature Communications Medicine tracked 810,851 people after COVID.
Only 1.4% received an official post-COVID-19 condition (PCC) diagnosis - but that reflects only those who made it into the system.
Real prevalence of long COVID is many times higher🧵
Who was most likely to be diagnosed with PCC?
severe acute infection
unvaccinated status
female sex, older age
higher education, essential jobs (healthcare, teachers, drivers…)
pre-existing conditions - asthma, thrombosis, fibromyalgia, depression, anxiety, stress disorders
Biological core of the findings
Severity of acute infection
The strongest predictor by far.
The more severe the acute phase, the higher the PCC risk - stronger inflammation, higher viral load, and deeper tissue injury mean a greater chance some immune processes remain stuck on.